Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5

Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is known to cause various systemic problems including Metabolic Syndrome (MetS). MetS is a group of cardiovascular risk factors. By assessing MetS, one can assess the cardiovascular disease risk. There is increasing evidence of MetS in COPD patients. However, the frequency of MetS and its individual components are not still been clearly shown which is likely to vary in different population. Aim: To know the extent of association of metabolic syndrome and its components in patients with COPD. Materials and Methods: This study was designed as an analytical case control study. Ninety cases of COPD satisfying the inclusion criteria and 45 healthy volunteer subjects as controls were recruited over 18 months duration. Simple random sampling method was used to select all cases attending outdoor and indoor medicine department. All subjects (cases and controls) were matched for age, sex, occupation and socioeconomic status. Prior to participation in the study, written informed consent was taken from all subjects. All included subjects underwent a detailed history, clinical examination and laboratorial analysis. All subjects were assessed for MetS by using National Cholesterol Education Program-Third Adult Treatment Panel (NCEP ATP III) and International Diabetic Federation (IDF) criteria. Results: The present study demonstrated Metabolic Syndrome (MetS) in COPD according to NCEP ATP III and IDF criteria as 14 (15.56%) and 30 (33.33%) while there was no association of MetS with controls. The frequency of its component such as abdominal obesity, systolic blood pressure, diastolic blood pressure, elevated triglyceride, reduced HDL-C and elevated fasting glucose respectively was 71 (78.89%), 25 (26.67%), 12 (13.33%), 18 (20%), 23 (25.56%) and 17 (18.78%) respectively. Dyslipidemia was found in 36 (40%) cases of COPD including 16 (17.78%) cases of elevated LDL cholesterol. Conclusion: Our study concluded that MetS is frequent in COPD patients as compared to general population. Therefore, a comprehensive medical approach to screen all COPD patients for MetS should be done there to lower the significant risk of cardiovascular events in patients with COPD.

Authors and Affiliations

Kamlesh Kumar Gupta, Jitendra Singh, Pradeep Gupta, ML Patel, Vivek Kumar, Shyam Chand Chaudhary

Keywords

Related Articles

Middle Ear Risk Index Scores as a Predictor for Hearing Threshold after Tympanoplasty in Patients with Chronic Suppurative Otitis Media

ABSTRACT Introduction: One of the main purposes of tympanoplasty is to improve hearing. Middle Ear Risk Index (MERI) Scores can be use to predict the average success in the procedure of the middle ear reconstruction. Aim...

Plasma Cell Disorders in HIV Infected Patients: A Case Series

People Living with HIV (PLHIV) are at an increased risk of developing malignancies. Plasma cell disorders are also reported with increased incidence in PLHIV compared to the general population. Here, we describe three di...

Rigid Bronchoscopy and Jet Ventilation in Foreign Body Aspiration in A Two-Year-Old Female: A Case Report

ABSTRACT Foreign body aspiration is a leading cause of mortality in children of age group 1-3 years and presents significant challenges to the anaesthesiologist in maintaining oxygenation and ventilation while there is i...

Effects of 60° Semi-recumbent Position on Preventing Ventilator-associated Pneumonia: A Single-blind Prospective Randomised Clinical Trial

Introduction: Head-of-Bed Elevation (HOBE) is now considered as a main modifiable factor for decreasing Ventilator-Associated Pneumonia (VAP) especially in the area of intensive care nursing. Despite numerous studies on...

The Ethical Principles in Pharmacist-Patient Relationship

ABSTRACT As the pharmaceutical services are growing these days, author witness an increase in relationship between the pharmacists and patients. So, the legitimacy of their interaction plays an important role. In the pre...

Download PDF file
  • EP ID EP342471
  • DOI 10.7860/JCDR/2017/26488.9829
  • Views 91
  • Downloads 0

How To Cite

Kamlesh Kumar Gupta, Jitendra Singh, Pradeep Gupta, ML Patel, Vivek Kumar, Shyam Chand Chaudhary (2017). Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India. Journal of Clinical and Diagnostic Research, 11(5), 8-11. https://europub.co.uk/articles/-A-342471